ArticleFrontiers in immunology2026

Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F-mutated essential thrombocythemia: a case report.

Yutaro Ashida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.